Updated : Wed, October 1, 2014 @ 4:45 PM
Originally published : Wed, Oct 20, 2010 @ 08:12 AM
Updated : Wed, October 1, 2014 @ 4:45 PM
Originally published : Wed, Oct 20, 2010 @ 08:12 AM
Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has licensed access to the BHQ®, CAL Fluor® and Quasar® patents to Seegene (KOSDAQ; Korea Securities Dealers Automated Quotations).
To read the entire story, read the full press release.
LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.
Leave a comment